THORLNC and renal cell carcinoma: Collectively, ginsenosides exhibit direct anti-cancer activity and improve drug sensitivity for renal cell carcinoma via regulation of lncRNA THOR, epigenetic remodeling, and Nrf2-mediated ferroptosis (Table 4).